Xeris Biopharma Inc. (XERS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xeris Biopharma Inc.

    NASDAQ: XERS · Real-Time Price · USD
    7.85
    -0.04 (-0.51%)
    At close: Sep 05, 2025, 3:59 PM
    7.86
    0.13%
    After-hours: Sep 05, 2025, 07:49 PM EDT

    Xeris Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 203.07M 163.91M 110.25M 49.59M
    Cost of Revenue
    		 36.83M 28.64M 22.63M 13.32M
    Gross Profit
    		 166.24M 135.27M 87.61M 36.27M
    Operating Income
    		 -33.65M -44.01M -81.94M -115.16M
    Interest Income
    		 5.32M 4.75M 2.58M 313K
    Pretax Income
    		 -57.1M -63.5M -96.08M -122.72M
    Net Income
    		 -54.84M -62.26M -94.66M -122.72M
    Selling & General & Admin
    		 163.48M 146.09M 137.75M 125.72M
    Research & Development
    		 25.56M 22.34M 20.97M 25.16M
    Other Expenses
    		 10.84M 10.84M 10.84M 550K
    Operating Expenses
    		 199.88M 179.28M 169.55M 151.43M
    Interest Expense
    		 33.17M 26.61M 14.1M 7.18M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 236.72M 207.92M 192.19M 164.75M
    Income Tax Expense
    		 -2.27M -1.25M -1.42M n/a
    Shares Outstanding (Basic)
    		 146.77M 137.67M 135.63M 79.03M
    Shares Outstanding (Diluted)
    		 146.77M 137.67M 135.63M 79.03M
    EPS (Basic)
    		 -0.37 -0.45 -0.7 -1.55
    EPS (Diluted)
    		 -0.37 -0.45 -0.7 -1.55
    EBITDA
    		 -13.99M -23.73M -69.31M -113.67M
    EBIT
    		 -26.62M -36.9M -81.98M -115.55M
    Depreciation & Amortization
    		 12.63M 13.16M 12.67M 1.88M

    Add to Watchlist